Artificial Intelligence
What Is Adversarial Artificial Intelligence And Why Does It Matter?
Artificial intelligence (AI) is quickly becoming a critical component in how government, business and citizens defend themselves against cyber attacks. Starting with technology designed to automate specific manual tasks, and advancing to machine learning using increasingly complex systems to parse data, breakthroughs in deep learning capabilities will become an integral part of the security agenda. …
We Have Greater Moral Obligations To Robots Than To Humans
Down goes HotBot 4b into the volcano. The year is 2050 or 2150, and artificial intelligence has advanced sufficiently that such robots can be built with human-grade intelligence, creativity and desires. HotBot will now perish on this scientific mission. Does it have rights? In commanding it to go down, have we done something morally wrong? …
Are We Well-Equipped Against Fraudulent Biometrics Authentication?
The biometrics industry is booming as of late. A world dominated by biometric systems will be convenient and cost-saving for us. However, in light of the security attacks that we have experienced over the past years, security is a highly valid concern. How secure is the existing infrastructure of our biometric systems? Difficult to forge …
What Science Fiction Tells Us About Our Trouble With AI
AI, as conceived of in popular culture, does not yet exist, even if autonomous and expert systems do. Smartphones might not be supercomputers, but they are called “smartphones” for good reason, in terms of how their operating systems function. Equally, we are happy to talk about a computer game’s “AI”, but gamers quickly learn to …
It Could Be Time To Start Thinking About A Cybernetic Bill Of Rights
Like it or loathe it, the robot revolution is now well underway and the futures described by writers such as Isaac Asimov, Frederik Pohl and Philip K. Dick are fast turning from science fiction into science fact. But should robots have rights? And will humanity ever reach a point where human and machine are treated …
IBM AI Innovations Sharpen Risk Detection In Identity Management
IBM Security announced last 10 December 2019 that it is extending its artificial intelligence (AI) technology originally developed to protect users in the financial services industry, to clients in all industries via the company’s identity-as-a-service (IDaaS) offering. IBM Cloud Identity now features AI-based adaptive access capabilities that help continually assess employee or consumer user risk …
Huawei and Peng Cheng Laboratory Build Cloud Brain II, Embarking on a New Chapter for AI Clusters at 1000 PFLOPS Scale
Huawei and Peng Cheng Laboratory (PCL) jointly released Peng Cheng Cloud Brain II Phase 1 last 29 November 2019, officially launching the journey to AI clusters at 1000 petaFLOPS (PFLOPS) scale. This marks a new milestone in the scientific research field for the Kunpeng computing industry. Running at the bedrock of Cloud Brain II is …
Algorithms Might Be Everywhere, But Like Us, They’re Deeply Flawed
What’s the problem? As algorithms become entrenched into society, the debate about their effects rages on. In essence, algorithms are sequences of instructions used to solve problems and perform functions in computer programming. As mathematical expressions, algorithms existed long before modern computers. While they vary in application, all algorithms have three things in common: clearly-defined …
Global AI Survey: AI Proves Its Worth, But Few Scale Impact
While AI continues to enjoy a continuously increasing adoption in 2019, much work is still needed in order for it to create significant impact — McKinsey reveals in their released 2019 Global AI Survey paper. Let’s look further into the main findings of this year’s survey. Most respondents are seeing returns from AI 63 percent of …
A.I. Predicts Which Drug Combos Will Best Treat TB
With a shortage of new tuberculosis drugs in the pipeline, a software tool can predict how current drugs—including unlikely candidates—can combine in new ways to create more effective treatments. “This could replace our traditional trial-and-error system for drug development that is comparatively slow and expensive,” says Sriram Chandrasekaran, assistant professor of biomedical engineering at the …